xylocaine
Generic: lidocaine hydrochloride,epinephrine bitartrate
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
xylocaine
Generic Name
lidocaine hydrochloride,epinephrine bitartrate
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
epinephrine bitartrate .01 mg/mL, lidocaine hydrochloride anhydrous 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-482
Product ID
63323-482_0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA006488
Listing Expiration
2026-12-31
Marketing Start
2010-08-12
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323482
Hyphenated Format
63323-482
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
xylocaine (source: ndc)
Generic Name
lidocaine hydrochloride,epinephrine bitartrate (source: ndc)
Application Number
NDA006488 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .01 mg/mL
- 10 mg/mL
Packaging
- 25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-26) / 20 mL in 1 VIAL, MULTI-DOSE (63323-482-41)
Packages (1)
Ingredients (2)
Linked Drug Pages (2)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INFILTRATION", "PERINEURAL"], "spl_id": "0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33", "openfda": {"upc": ["0363323486419", "0363323495411", "0363323492434", "0363323482411", "0363323485412", "0363323492458", "0363323492410"], "unii": ["30Q7KI53AK", "EC2CNF7XFP"], "rxcui": ["1010033", "1010035", "1010671", "1010673", "1010751", "1010755", "1737562", "1737563", "1737566", "1737567", "1737568", "1737569", "1737570", "1737571", "1737757", "1737758", "1737761", "1737762"], "spl_set_id": ["4dd52202-8eef-4136-92dd-ada573b7cf74"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-26) / 20 mL in 1 VIAL, MULTI-DOSE (63323-482-41)", "package_ndc": "63323-482-26", "marketing_start_date": "20100812"}], "brand_name": "Xylocaine", "product_id": "63323-482_0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Catecholamine [EPC]", "Catecholamines [CS]", "Local Anesthesia [PE]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "63323-482", "generic_name": "LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Xylocaine", "active_ingredients": [{"name": "EPINEPHRINE BITARTRATE", "strength": ".01 mg/mL"}, {"name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "strength": "10 mg/mL"}], "application_number": "NDA006488", "marketing_category": "NDA", "marketing_start_date": "20100812", "listing_expiration_date": "20261231"}